Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Aegerion Pharmaceuticals Inc (NASDAQ:AEGR)

During the Trading Day
6.18 -0.22 / -3.44%
As of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
6.18 0.00 / 0.00%
 
Volume: 542.00

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2014
Quarter 1
2015
Quarter 2
2015
Quarter 3
2015
Revenue and IncomeNet Revenues51.7M59.4M64.2M67.3M
 
 
 
 
 
Cost of Goods Sold3.4M6.2M8.7M8.9M
 
 
 
 
 
Depreciation And Amortization413.0K5.6M5.3M5.6M
 
 
 
 
 
 
Operating ExpensesGross Income47.9M47.5M50.2M52.8M
 
 
 
 
 
General Expenses47.9M56.7M55.1M55.2M
 
 
 
 
 
Research And Development10.7M9.8M12.5M11.3M
 
 
 
 
 
Total Operating Expenses51.6M68.6M69.1M69.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income76.0K-9.2M-4.9M-2.4M
 
 
 
 
 
Extraordinary Charge-1.0K0.000.000.00
 
 
Interest Expense On Debt6.4M6.9M7.1M7.1M
 
 
 
 
 
Other Expenses-1.4M485.0K1.1M30.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-7.7M-15.6M-10.9M-9.5M
 
 
 
 
 
Income Taxes-372.0K-199.0K-254.0K-294.0K
 
 
 
 
 
Net Income-8.1M-15.8M-11.2M-9.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS28.4M28.5M28.6M28.7M
 
 
 
 
 
Shares To Calculate EPS Diluted28.4M28.5M28.6M28.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.29-$0.55-$0.39-$0.34
 
 
 
 
 
EPS Diluted-$0.29-$0.55-$0.39-$0.34